Key facts
- D1 Capital Partners L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value (LXEO).
- Disclosed ownership: 2.9%.
- Date of event: 31 Mar 2025.
D1 Capital Partners L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value (LXEO)
- Filing manager
- D1 Capital Partners L.P.
- Reporting owner
- D1 Capital Partners L.P.
- Symbol
- LXEO
- Shares outstanding
- 33,746,621 shares
- Disclosed shares
- 978,652 shares
- Ownership percentage
- 2.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 09:58:26 UTC
- Event date
- 31 Mar 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
D1 Capital Partners L.P. disclosed 2.9% ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value (LXEO) on 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 09:58.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| D1 Capital Partners L.P. | 2.9% | 978,652 | 0 | 978,652 | /s/ Amanda Hector | Amanda Hector, General Counsel and Chief Compliance Officer | |
| Daniel Sundheim | 2.9% | 978,652 | 0 | 978,652 | /s/ Daniel Sundheim | Daniel Sundheim, Individually |
CIK / CUSIP context first